Literature DB >> 26964816

Diabetes mellitus and its influence on sputum smear positivity at the 2nd month of treatment among pulmonary tuberculosis patients in Kuala Lumpur, Malaysia: A case control study.

Noorsuzana Mohd Shariff1, Nazarudin Safian2.   

Abstract

OBJECTIVE/
BACKGROUND: Many studies have suggested that sputum smear conversion after 2 months of antituberculosis treatment is an important determinant of treatment success and can be a predictor for relapse. The objective of this study is to determine the factors that influence sputum smear conversion after 2 months of treatment among pulmonary tuberculosis patients receiving treatment in the Institute of Respiratory Medicine in Kuala Lumpur, Malaysia.
METHODS: A total of 75 cases and 75 controls were interviewed, and their medical records were retrieved in order to extract the information needed. All analyses were conducted using SPSS version 17, and binary logistic regression analysis was used to determine the predictors of sputum smear nonconversion.
RESULTS: Results showed that the following factors were associated with sputum smear positivity after 2 months of intensive treatment: diabetes mellitus (p=.013, odds ratio [OR]=2.59, 95% confidence interval [CI] 1.27-5.33), underweight body mass index (p=.025, OR=1.67, 95% CI 0.80-3.49), nonadherent to tuberculosis treatment (p=.024, OR=2.85, 95% CI 1.21-6.74), and previous history of tuberculosis (p=.043, OR=2.53, 95% CI 1.09-5.83). Multivariable analysis identified diabetes mellitus (p=.003, OR=4.01, 95% CI 1.61-9.96) as being independently associated with the risk of persistent sputum smear positivity after 2 months of intensive treatment.
CONCLUSION: Based on the findings, identification of these factors is valuable in strengthening the management and treatment of tuberculosis in Malaysia in the future. This study emphasizes the importance of diabetes screening and integration of diabetic controls among tuberculosis patients in achieving better treatment outcome.
Copyright © 2015 Asian-African Society for Mycobacteriology. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Risk factors; Sputum smear nonconversion; Tuberculosis

Mesh:

Substances:

Year:  2015        PMID: 26964816     DOI: 10.1016/j.ijmyco.2015.09.003

Source DB:  PubMed          Journal:  Int J Mycobacteriol        ISSN: 2212-5531


  12 in total

1.  Prevalence and Impact of Diabetes Mellitus Among Patients with Active Pulmonary Tuberculosis in South Korea.

Authors:  Eun Hye Lee; Jung Mo Lee; Young Ae Kang; Ah Young Leem; Eun Young Kim; Ji Ye Jung; Moo Suk Park; Young Sam Kim; Se Kyu Kim; Joon Chang; Song Yee Kim
Journal:  Lung       Date:  2017-02-09       Impact factor: 2.584

2.  Diabetes Mellitus and Tuberculosis Comorbidity and Associated Factors Among Bale Zone Health Institutions, Southeast Ethiopia.

Authors:  Habtamu Gezahegn; Mohammed Ibrahim; Elias Mulat
Journal:  Diabetes Metab Syndr Obes       Date:  2020-10-21       Impact factor: 3.168

Review 3.  Molecular clustering of patients with diabetes and pulmonary tuberculosis: A systematic review and meta-analysis.

Authors:  Francles Blanco-Guillot; Guadalupe Delgado-Sánchez; Norma Mongua-Rodríguez; Pablo Cruz-Hervert; Leticia Ferreyra-Reyes; Elizabeth Ferreira-Guerrero; Mercedes Yanes-Lane; Rogelio Montero-Campos; Miriam Bobadilla-Del-Valle; Pedro Torres-González; Alfredo Ponce-de-León; José Sifuentes-Osornio; Lourdes Garcia-Garcia
Journal:  PLoS One       Date:  2017-09-13       Impact factor: 3.240

4.  Genotyping and spatial analysis of pulmonary tuberculosis and diabetes cases in the state of Veracruz, Mexico.

Authors:  Francles Blanco-Guillot; M Lucía Castañeda-Cediel; Pablo Cruz-Hervert; Leticia Ferreyra-Reyes; Guadalupe Delgado-Sánchez; Elizabeth Ferreira-Guerrero; Rogelio Montero-Campos; Miriam Bobadilla-Del-Valle; Rosa Areli Martínez-Gamboa; Pedro Torres-González; Norma Téllez-Vazquez; Sergio Canizales-Quintero; Mercedes Yanes-Lane; Norma Mongua-Rodríguez; Alfredo Ponce-de-León; José Sifuentes-Osornio; Lourdes García-García
Journal:  PLoS One       Date:  2018-03-13       Impact factor: 3.240

5.  The Negative Clinical Impact of Diabetes on Tuberculosis: A Cross-Sectional Study in New Jersey.

Authors:  Charles F Kreisel; Marian R Passannante; Alfred A Lardizabal
Journal:  J Endocr Soc       Date:  2018-11-14

6.  TB-diabetes co-morbidity in Ghana: The importance of Mycobacterium africanum infection.

Authors:  Adwoa Asante-Poku; Prince Asare; Nyonuku Akosua Baddoo; Audrey Forson; Pius Klevor; Isaac Darko Otchere; Sammy Yaw Aboagye; Stephen Osei-Wusu; Emelia Konadu Danso; Kwadwo Koram; Sebastien Gagneux; Dorothy Yeboah-Manu
Journal:  PLoS One       Date:  2019-02-07       Impact factor: 3.240

7.  Sputum smear non-conversion among adult persons with bacteriologically confirmed pulmonary tuberculosis in rural eastern Uganda.

Authors:  Jonathan Izudi; Imelda K Tamwesigire; Francis Bajunirwe
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2020-05-30

8.  Slow radiological improvement and persistent low-grade inflammation after chemotherapy in tuberculosis patients with type 2 diabetes.

Authors:  Akhirunnesa Mily; Protim Sarker; Inin Taznin; Delwar Hossain; Md Ahsanul Haq; S M Mostofa Kamal; Birgitta Agerberth; Susanna Brighenti; Rubhana Raqib
Journal:  BMC Infect Dis       Date:  2020-12-07       Impact factor: 3.090

9.  Dysglycemia is associated with Mycobacterium tuberculosis lineages in tuberculosis patients of North Lima-Peru.

Authors:  Kattya Lopez; María B Arriaga; Juan G Aliaga; Nadia N Barreda; Oswaldo M Sanabria; Chuan-Chin Huang; Zibiao Zhang; Ruth García-de-la-Guarda; Leonid Lecca; Anna Cristina Calçada Carvalho; Afrânio L Kritski; Roger I Calderon
Journal:  PLoS One       Date:  2021-01-28       Impact factor: 3.240

10.  Determinants of sputum smear nonconversion in smear-positive pulmonary tuberculosis patients in Suriname, 2010 - 2015.

Authors:  Eric Commiesie; Deborah Stijnberg; Diana Marín; Freddy Perez; Mauro Sanchez
Journal:  Rev Panam Salud Publica       Date:  2019-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.